Navigation Links
Therapure Biopharma Inc. and Akorn, Inc. Announce Strategic Supply Contract
Date:12/11/2009

Therapure to provide specialized formulation and fill services

(PRWEB) December 11, 2009 -- Therapure Biopharma Inc. today announced the signing of an exclusive supply agreement with Akorn Inc. (NASDAQ: AKRX). This agreement will support Akorn’s new product development initiatives.

Under the terms of the partnership, Therapure Biopharma will provide product formulation, process development, and sterile fill/finish services to support the development of new hospital products by Akorn. Therapure Biopharma will provide these services in its Health Canada licensed facility in Mississauga, Ontario.

“We are proud that Akorn has chosen Therapure Biopharma as a strategic partner for the development of these new products,” said Thomas Wellner President and CEO of Therapure Biopharma Inc. “Therapure Biopharma has experience in meeting the needs of customers for specialized fill/finish services and we were able to respond quickly to Akorn’s particular requirements.”

“Akorn carries a broad catalogue of sterile specialty pharmaceutical products”, said Sean Brynjelsen, Akorn’s Vice President of New Business Development. “Therapure Biopharma was able to quickly respond to our need for specialty formulation and fill/finish services. The signing of this exclusive supply agreement reinforces Akorn’s commitment to expanding our portfolio through partnering.”


About Therapure Biopharma:

Therapure Biopharma Inc. is an integrated biopharmaceutical company that develops, manufactures, purifies, and packages therapeutic proteins. As a contract development and manufacturing organization (CDMO) Therapure Biopharma applies scientific, manufacturing, and downstream purification expertise with an intimate understanding of advanced biology, complex proteins, and regulatory processes to develop effective and innovative solutions to advance products from discovery to market.

For more information, please visit: www.therapurebio.com

About Akorn, Inc.

Akorn, Inc. manufactures and markets sterile specialty pharmaceuticals. Akorn has manufacturing facilities located in Decatur, Illinois and Somerset, New Jersey and markets and distributes an extensive line of hospital and ophthalmic pharmaceuticals.

For more information, please visit www.akorn.com.

# # #

Read the full story at http://www.prweb.com/releases/2009/12/prweb3316884.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Therapure Biopharma Inc. and LFB Biotechnologies Announce Development Services Contract for New Therapeutic Protein
2. Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer
3. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
4. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
5. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
6. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
8. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
9. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
10. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
11. CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... availability of video chat as a standard feature on its secure clinical communication ... text to voice to video depending on the type and urgency of a ...
(Date:5/23/2017)... ... ... New patients with symptoms of gum disease in San Diego, ... treatments from the doctors at Art of Dentistry, without first receiving a referral. Drs. ... of receiving qualified treatment in order to avoid systemic health effects associated with untreated ...
(Date:5/23/2017)... Mt. Horeb, WI (PRWEB) , ... May 23, 2017 , ... ... now invited to call Dr. Angela Cotey’s practice to schedule an appointment, with or ... dentistry services, and frequently offers pulpotomy treatments to pediatric patients as a healthy alternative ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... now welcoming new patients with periodontal plastic surgery treatments, including crown lengthening ... dentist. Dr. Green provides these esthetic and functional procedures to help patients improve ...
(Date:5/22/2017)... ... May 22, 2017 , ... “Homeostasis: The Journey of ... to live with Bipolar 1. Donald Rodriguez takes readers on a rollercoaster ride that ... the dead of winter and to a dark place where Donald considers suicide. ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... May 9, 2017  Semler Scientific, Inc. (OTCQB: ... solutions to improve the clinical effectiveness and efficiency ... the first quarter ended March 31, 2017. ... our customers to identify when preventive care options ... events like heart attacks or strokes occur," said ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
(Date:5/4/2017)... MONTREAL , May 4, 2017  Fortuna Fix Inc. (" ... aiming to be the first to eliminate the need for ... autologous cells to treat neurodegenerative diseases. Fortuna ... ("SAB") with Professor Michael Fehlings , MD, PhD; Father ... Hack , MD, MPH; and Professor James Giordano , ...
Breaking Medicine Technology: